[ad_1]
The only vaccine to prevent tick-borne encephalitis – responsible for severe brain damage – in children, recommended for certain trips, is out of stock until the end of July 2018 at the earliest, announced July 17 2018 the French Medicines Agency (ANSM). " Out of stock since July 9 ," says the ANSM on its website, about the vaccine Ticovac 0.25 ml children, Pfizer laboratory. " Provisional release scheduled from the week of July 30 " 2018, adds the agency.
A very rare disease in France
The Ticovac vaccine for adolescents and adults (0.5 ml) is also out of stock, and that " since June 19" . But there remains a competing vaccine available in pharmacy, GlaxoSmithKline's Encépur Laboratories, which can be injected from the age of 12.
Tick-borne encephalitis is a viral disease transmitted by the bite of these insects. It can cause serious infections of the brain or spinal cord and meninges. Vaccination is recommended by the French health authorities when traveling " in rural or wooded areas in endemic regions (Central, Eastern and Northern Europe, northern central Asia, northern China, north of Japan) from spring to autumn ". Two countries bordering France, Switzerland and Germany, and many others, are concerned, as far as Sweden and Finland to the north, Greece to the south, and Japan to the east. In France, however, this vaccination is not necessary since the disease is very rare (about three cases per year according to the researchers).
Source link
